Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,938 | 451 | 84.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $934.00 | 1 | 8.9% |
| Education | $664.36 | 9 | 6.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,748 | 125 | $0 (2024) |
| GENZYME CORPORATION | $1,651 | 33 | $0 (2023) |
| Janssen Biotech, Inc. | $1,422 | 61 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $745.68 | 39 | $0 (2024) |
| LEO Pharma Inc. | $504.36 | 30 | $0 (2024) |
| PFIZER INC. | $482.28 | 28 | $0 (2024) |
| Lilly USA, LLC | $402.00 | 22 | $0 (2024) |
| Celgene Corporation | $398.15 | 29 | $0 (2019) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $353.25 | 12 | $0 (2024) |
| Amgen Inc. | $256.23 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,524 | 63 | ABBVIE INC. ($496.50) |
| 2023 | $1,106 | 42 | ABBVIE INC. ($313.57) |
| 2022 | $2,239 | 58 | GENZYME CORPORATION ($1,017) |
| 2021 | $353.54 | 19 | AbbVie Inc. ($80.96) |
| 2020 | $351.19 | 19 | AbbVie Inc. ($113.25) |
| 2019 | $1,544 | 83 | AbbVie, Inc. ($537.00) |
| 2018 | $1,719 | 87 | AbbVie, Inc. ($429.24) |
| 2017 | $1,700 | 90 | AbbVie, Inc. ($436.34) |
All Payment Transactions
461 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.83 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Immunology | ||||||
| 10/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.77 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Musculoskeletal Transplant Foundation Inc. | — | Food and Beverage | In-kind items and services | $12.92 | General |
| 08/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Dermatology | ||||||
| 08/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/31/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: DERMATOLOGY | ||||||
| 07/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.66 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Dermatology | ||||||
| 07/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.53 | General |
| Category: Dermatology | ||||||
| 06/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Immunology | ||||||
| 06/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,611 | 5,402 | $427,766 | $186,304 |
| 2022 | 23 | 2,802 | 6,245 | $452,739 | $207,047 |
| 2021 | 25 | 3,271 | 6,985 | $704,155 | $250,357 |
| 2020 | 24 | 3,659 | 7,330 | $1.2M | $222,886 |
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 788 | 1,089 | $121,968 | $58,282 | 47.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 492 | 638 | $63,162 | $24,277 | 38.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 242 | 270 | $40,230 | $17,835 | 44.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 73 | 80 | $36,880 | $17,222 | 46.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 400 | 2,635 | $23,715 | $12,414 | 52.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 59 | 69 | $15,870 | $8,503 | 53.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 114 | 114 | $18,582 | $7,257 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 86 | $14,104 | $6,817 | 48.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 43 | 48 | $20,640 | $5,375 | 26.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 62 | 102 | $8,262 | $3,937 | 47.7% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 16 | 16 | $7,296 | $3,724 | 51.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 45 | 45 | $7,515 | $3,632 | 48.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 33 | 36 | $13,572 | $3,466 | 25.5% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 13 | 14 | $6,286 | $3,065 | 48.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 54 | 55 | $3,740 | $2,065 | 55.2% |
| 69100 | Biopsy of ear | Office | 2023 | 31 | 32 | $4,768 | $1,867 | 39.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 19 | $5,073 | $1,861 | 36.7% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 17 | 18 | $7,002 | $1,790 | 25.6% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 13 | 14 | $5,768 | $1,474 | 25.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $2,068 | $1,091 | 52.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $1,265 | $347.79 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 877 | 1,194 | $133,728 | $67,623 | 50.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 557 | 733 | $72,567 | $28,792 | 39.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 226 | 253 | $37,697 | $17,166 | 45.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 467 | 3,300 | $29,700 | $16,351 | 55.1% |
About Dr. Gary Gross, M.D
Dr. Gary Gross, M.D is a Dermatology healthcare provider based in Salem, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043299639.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Gross, M.D has received a total of $10,537 in payments from pharmaceutical and medical device companies, with $1,524 received in 2024. These payments were reported across 461 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($8,938).
As a Medicare-enrolled provider, Gross has provided services to 12,343 Medicare beneficiaries, totaling 25,962 services with total Medicare billing of $866,594. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Salem, VA
- Active Since 01/11/2006
- Last Updated 08/16/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1043299639
Products in Payments
- DUPIXENT (Biological) $1,382
- Humira (Biological) $1,203
- SKYRIZI (Biological) $896.27
- TREMFYA (Drug) $775.32
- COSENTYX (Biological) $671.89
- Tremfya (Drug) $436.51
- DUPIXENT (Drug) $413.20
- TALTZ (Drug) $402.00
- ENSTILAR (Drug) $385.17
- EUCRISA (Drug) $369.22
- RINVOQ (Biological) $360.34
- REMICADE (Biological) $274.21
- Sotyktu (Drug) $222.50
- Enbrel (Biological) $194.84
- Skyrizi (Biological) $176.86
- Cimzia (Drug) $163.35
- OPZELURA (Drug) $155.13
- STELARA (Biological) $133.64
- Otezla (Drug) $116.22
- CIBINQO (Drug) $113.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Salem
Dr. Russell Young, Md, MD
Dermatology — Payments: $10,674
Lacey Roybal, D.o, D.O
Dermatology — Payments: $7,933
Paarth Dodia, Do, DO
Dermatology — Payments: $7,518
Dr. Patrick Whitman, Do, DO
Dermatology — Payments: $7,329
Dr. Preston Chadwick, M.d, M.D
Dermatology — Payments: $6,596
Reyna Swift
Dermatology — Payments: $4,899